Login
Toggle navigation
Login
Cart
Contact Us
Search
Search
×
Innovative Vaccine Approaches | EK50
Displaying 1 - 10 of 58
First
«
1
2
3
4
5
»
Last
Sessions
INO-4800 DNA Vaccine Induces Neutralizing Antibodies and T cell Activity Against Global SARS-CoV-2 Variants
Preview Available
INO-4800 DNA Vaccine Induces Neutralizing Antibodies and T cell Activity Against Global SARS-CoV-2 Variants
Speaker(s):
Viviane M. Andrade
, PhD, Inovio Pharmaceuticals Inc.
Epitope identification of SARS-CoV-2 structural proteins using in silico approaches to obtain conserved rational immunogenic peptide
Preview Available
Epitope identification of SARS-CoV-2 structural proteins using in silico approaches to obtain conserved rational immunogenic peptide
Speaker(s):
Leonardo A. de Almeida
, PhD, Universidade Federal de Alfenas
BCG & Cyclic Dinucleotides join hands in fight against Tuberculosis and Viral Diseases- Novel approach towards developing a low cost PAN Corona vaccine.
Preview Available
BCG & Cyclic Dinucleotides join hands in fight against Tuberculosis and Viral Diseases- Novel approach towards developing a low cost PAN Corona vaccine.
Speaker(s):
Ruchi Jain Dey
, PhD, BITS Pilani Hyderabad Campus
First recombinant dual-hit glycoconjugate vaccine production platform to combat Group A Streptococcus
Preview Available
First recombinant dual-hit glycoconjugate vaccine production platform to combat Group A Streptococcus
Speaker(s):
Helge C. Dorfmueller
, PhD, University of Dundee
Stabilization of the SARS-CoV-2 Spike receptor-binding domain using deep mutational scanning and structure-based design
Preview Available
Stabilization of the SARS-CoV-2 Spike receptor-binding domain using deep mutational scanning and structure-based design
Speaker(s):
Daniel Ellis
, PhD, University of Washington
Assessing RNA recombination between an alphavirus replicon vector vaccine and wildtype alphaviruses
Preview Available
Assessing RNA recombination between an alphavirus replicon vector vaccine and wildtype alphaviruses
Speaker(s):
Tessy A. Hick
, MSc, Wageningen University
Sterilizing Antiviral Immunity Induced by a CD40L-Based Vaccine
Preview Available
Sterilizing Antiviral Immunity Induced by a CD40L-Based Vaccine
Speaker(s):
Richard Kornbluth
, MD, PhD, Multimeric Biotherapeutics, Inc.
Using synthetic biology to generate rapidly manufacturable hyper-stable vaccines
Preview Available
Using synthetic biology to generate rapidly manufacturable hyper-stable vaccines
Speaker(s):
John J. Miles
, PhD, James Cook University
Vaccine nanoparticles for elicitation of strong cellular and humoral immune responses.
Preview Available
Vaccine nanoparticles for elicitation of strong cellular and humoral immune responses.
Speaker(s):
James J. Moon
, PhD, University of Michigan, Ann Arbor
COVID-19 Pathogen (SARS-Cov-2) Viral Evolution Leading to Increased Infectivity
Preview Available
COVID-19 Pathogen (SARS-Cov-2) Viral Evolution Leading to Increased Infectivity
Speaker(s):
Sonam Parag
, BS, Nova Southeastern University Dr. Kiran C. Patel College of Allopathic Medicine
Displaying 1 - 10 of 58
First
«
1
2
3
4
5
»
Last
×
Evaluation
×
Shopping Cart
Item
Price
Remove